samedan logo
 
 
 
spacer
home > ebr > autumn 2002 > to clone or not to clone: is politics preventing progress?
PUBLICATIONS
European Biopharmaceutical Review

To Clone or Not to Clone: Is Politics Preventing Progress?

Although US President George W. Bush has made it very clear to the American public that he favours a total ban on human cloning - whether for research or for reproductive purposes - legislation to do so has yet to pass muster in the US Senate. The subject of human cloning and stem cell research is being hotly debated in the US while scientists in other countries, unhampered by the prospect of a governmental ban, are forging ahead. Opponents to cloning fear the ethical and moral implications while proponents are keen to find the scientific answers that may one day lead to cures for Alzheimer's, Parkinson's, juvenile diabetes and a number of other debilitating diseases. Will we run amuck with this intensely powerful technology or learn to use it to our best advantage?


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By G. Steven Burrill, CEO of Burrill & Company

G. Steven Burrill is CEO of Burrill & Company, a San Francisco-based life sciences merchant bank. Mr Burrill currently serves on eight Boards of Directors including DepoMed (Amex: DMI) and Third Wave Technologies (NASDAQ: TWTI), and is Chairman of the Boards of Pyxis Genomics and Paradigm Genetics (NASDAQ: PDGM).
Prior to founding Burrill & Company in 1994, he spent 28 years with Ernst & Young, directing and co-ordinating the firm's services to clients in the biotechnology, life sciences, high technology and manufacturing industries worldwide.

spacer
G. Steven Burrill
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Nemera wins Pharmapack Award in Connected Devices and Wearables category with its body injector platform Symbioze

Symbioze, the smart, high volume and sustainable on-body injector platform developed by Nemera, wins the ‘Connected Devices and Wearables’ Award at Pharmapack 2021 On October 12th, during the Pharmapack Awards Ceremony, a team of industry experts awarded Symbioze, Nemera’s large-volume on-body injector, with the Pharmapack Award in the “Connected Devices and Wearables” category.
More info >>

White Papers

How To Increase Efficiency, Customer Satisfaction and Reduce Cost

AC Labels

A customer of Riverside Medical had required a complex four-part 'piggy back' label. The labels needed to be specially constructed to facilitate removal in parts at various stages of its use for quality control traceability. This label needed to carry variable data elements of LOT numbers, batch numbers and product descriptions, and also a secondary gamma indicator label placed on each of its 4 sections to prove its sterility following sterilisation.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement